- Home
- DOX vs ASND Comparison
DOX vs ASND Comparison
Compare DOX & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOX
- ASND
- Stock Information
- Founded
- DOX 1982
- ASND 2006
- Country
- DOX United States
- ASND Denmark
- Employees
- DOX N/A
- ASND N/A
- Industry
- DOX EDP Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- DOX Technology
- ASND Health Care
- Exchange
- DOX Nasdaq
- ASND Nasdaq
- Market Cap
- DOX 10.2B
- ASND 9.0B
- IPO Year
- DOX 1998
- ASND 2015
- Fundamental
- Price
- DOX $90.46
- ASND $145.74
- Analyst Decision
- DOX Strong Buy
- ASND Strong Buy
- Analyst Count
- DOX 5
- ASND 14
- Target Price
- DOX $101.20
- ASND $199.50
- AVG Volume (30 Days)
- DOX 678.4K
- ASND 565.4K
- Earning Date
- DOX 02-04-2025
- ASND 05-01-2025
- Dividend Yield
- DOX 2.33%
- ASND N/A
- EPS Growth
- DOX N/A
- ASND N/A
- EPS
- DOX 4.31
- ASND N/A
- Revenue
- DOX $4,869,845,000.00
- ASND $376,478,932.00
- Revenue This Year
- DOX N/A
- ASND $56.36
- Revenue Next Year
- DOX $4.21
- ASND $81.67
- P/E Ratio
- DOX $20.98
- ASND N/A
- Revenue Growth
- DOX N/A
- ASND 36.34
- 52 Week Low
- DOX $74.41
- ASND $111.09
- 52 Week High
- DOX $93.83
- ASND $158.00
- Technical
- Relative Strength Index (RSI)
- DOX 64.33
- ASND 51.50
- Support Level
- DOX $86.03
- ASND $146.23
- Resistance Level
- DOX $89.90
- ASND $155.98
- Average True Range (ATR)
- DOX 1.78
- ASND 6.14
- MACD
- DOX 0.07
- ASND -0.46
- Stochastic Oscillator
- DOX 89.13
- ASND 7.47
About DOX Amdocs Limited
Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.